J Domínguez-Ortega Selected Research

J Domínguez-Ortega Research Topics

Disease

20	Asthma (Bronchial Asthma) 02/2024 - 01/2013
11	Hypersensitivity (Allergy) 12/2021 - 11/2003
4	Rhinitis 09/2017 - 01/2009
4	Urticaria (Hives) 01/2014 - 01/2006
3	Drug Eruptions (Drug Eruption) 08/2019 - 01/2009
2	Inflammation (Inflammations) 10/2023 - 03/2023
2	Infections 01/2020 - 01/2007
2	Aspirin-Induced Asthma 04/2019 - 07/2002
2	Angioedema 01/2014 - 01/2006
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2024
1	Respiratory Hypersensitivity 10/2023
1	Polyps 02/2023
1	Reinfection 02/2023
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Exanthema (Rash) 04/2018
1	Drug Hypersensitivity Syndrome 04/2018
1	Vitiligo 01/2016
1	Dust Mite Allergy 01/2014
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2014
1	Allergic Rhinitis 01/2013
1	Eosinophilic Esophagitis 01/2009
1	Osteoporosis 01/2007
1	Pseudomonas Infections 01/2007
1	Fistula 01/2007
1	Bronchiectasis 01/2007
1	Bronchial Spasm 01/2007
1	Cellulitis 01/2006
1	Abscess 01/2006
1	Staphylococcal Infections 01/2006
1	Anaphylaxis (Anaphylactic Shock) 11/2003
1	Anisakiasis 05/2003

Drug/Important Bio-Agent (IBA)

6	Immunoglobulin E (IgE)IBA 10/2023 - 05/2003
6	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2023 - 01/2014
5	AllergensIBA 01/2018 - 01/2013
4	Interleukin-5 (Interleukin 5)IBA 01/2024 - 02/2021
4	mepolizumabIBA 03/2023 - 12/2017
3	reslizumabIBA 06/2023 - 12/2017
3	Omalizumab (Xolair)FDA Link 02/2023 - 01/2020
2	CytokinesIBA 10/2023 - 12/2017
2	Interleukin-13IBA 10/2023 - 02/2021
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2023 - 04/2019
2	Eosinophil Cationic ProteinIBA 03/2023 - 05/2003
2	Monoclonal AntibodiesIBA 03/2023 - 02/2023
2	benralizumabIBA 02/2023 - 12/2017
2	anti-IgE antibodiesIBA 02/2023 - 02/2021
2	dupilumabIBA 01/2023 - 02/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2019 - 07/2002
1	AntibodiesIBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	tezepelumabIBA 10/2023
1	Prednisone (Sone)FDA LinkGeneric 03/2023
1	Dipyrone (Metamizole)IBA 01/2023
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2023
1	BNT162 VaccineIBA 12/2021
1	Enterotoxins (Enterotoxin)IBA 04/2021
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 02/2021
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2020
1	EtoricoxibIBA 08/2019
1	Sulfadiazine (Sulphadiazine)FDA Link 04/2018
1	Sulfamethoxazole FDA LinkGeneric 04/2018
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2015
1	Bronchodilator Agents (Bronchodilators)IBA 01/2015
1	Muscarinic AntagonistsIBA 01/2015
1	Tiotropium Bromide (Spiriva)FDA Link 01/2015
1	Salmeterol Xinafoate (Serevent)FDA Link 01/2015
1	IronIBA 01/2014
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 01/2013
1	Propofol (Diprivan)FDA LinkGeneric 01/2010
1	Adalimumab (Humira)FDA Link 01/2009
1	Histamine Antagonists (Antihistamines)IBA 01/2009
1	Dimenhydrinate (DMH)FDA LinkGeneric 01/2009
1	Profilins (Profilin)IBA 01/2009
1	SaltsIBA 01/2007
1	Colistin (Coly-Mycin)FDA Link 01/2007
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2007
1	CalciumIBA 01/2007
1	calcium pidolateIBA 01/2007
1	Cefuroxime (Zinacef)FDA LinkGeneric 01/2006
1	Penicillins (Penicillin)FDA Link 01/2006
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2006
1	Cloxacillin (Tegopen)FDA Link 01/2006
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2003
1	SulfonamidesIBA 11/2003
1	DiureticsIBA 11/2003
1	Furosemide (Lasix)FDA LinkGeneric 11/2003
1	Immunoglobulins (Immunoglobulin)IBA 05/2003

Therapy/Procedure

5	Therapeutics 02/2024 - 01/2007
3	Biological Therapy 12/2022 - 12/2017
2	Immunotherapy 01/2016 - 01/2014
1	Nebulizers and Vaporizers (Inhaler) 01/2020
1	Oral Administration 11/2003